Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NephRx Corp.

www.nephrxcorp.com

Latest From NephRx Corp.

NephRx Corp.

Although no one has yet developed a drug for kidney failure, researchers have long maintained the hope that reversing kidney failure is an attainable goal, because the kidney is one of the few organs in the body capable of regenerating. NephRx Corp. is one of this number of hopefuls; it believes its family of growth factors will repair damaged renal cells, and potentially also serve in degenerative gastrointestinal disorders.
BioPharmaceutical

Start-Up Previews (6/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Gene Delivery, features profiles of ImaRx Therapeutics Inc., Intradigm Corp., Protiva Biotherapeutics Inc. and Tranzyme Inc. Plus these Selected Start-Ups across Health Care: FASgen Inc., Power Medical Interventions Inc., NephRx Corp. and Tessera Diagnostics Inc.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NephRx Corp.
  • Senior Management
  • Peter A Croden, Pres. & CEO
    Arthur R Diani, PhD, VP, R&D
  • Contact Info
  • NephRx Corp.
    Phone: (616) 387-8400
    PO Box 2316
    Portage, MI 49081
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register